Pablo R. Moya - Publications

Affiliations: 
National Institute of Mental Health, Bethesda, MD, United States 
Area:
neuropharmacology, serotonin

23/50 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Delgado-Acevedo C, Estay SF, Radke AK, Sengupta A, Escobar AP, Henríquez-Belmar F, Reyes CA, Haro-Acuña V, Utreras E, Sotomayor-Zárate R, Cho A, Wendland JR, Kulkarni AB, Holmes A, Murphy DL, ... ... Moya PR, et al. Correction: Behavioral and synaptic alterations relevant to obsessivecompulsive disorder in mice with increased EAAT3 expression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30787427 DOI: 10.1038/s41386-019-0331-x  0.335
2018 Delgado-Acevedo C, Estay SF, Radke A, Sengupta A, Escobar AP, Henríquez-Belmar F, Reyes C, Haro V, Utreras E, Sotomayor-Zárate R, Cho A, Wendland JR, Kulkarni AB, Holmes A, Murphy DL, ... ... Moya PR, et al. Behavioral and synaptic alterations relevant to obsessive-compulsive disorder in mice with increased EAAT3 expression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30622300 DOI: 10.1038/S41386-018-0302-7  0.432
2017 González LF, Henríquez-Belmar F, Delgado-Acevedo C, Cisternas-Olmedo M, Arriagada G, Sotomayor-Zárate R, Murphy DL, Moya PR. Neurochemical and behavioral characterization of neuronal glutamate transporter EAAT3 heterozygous mice. Biological Research. 50: 29. PMID 28927446 DOI: 10.1186/S40659-017-0138-3  0.441
2014 Sotomayor-Zárate R, Jara P, Araos P, Vinet R, Quiroz G, Renard GM, Espinosa P, Hurtado-Guzmán C, Moya PR, Iturriaga-Vásquez P, Gysling K, Reyes-Parada M. Improving amphetamine therapeutic selectivity: N,N-dimethyl-MTA has dopaminergic effects and does not produce aortic contraction. Basic & Clinical Pharmacology & Toxicology. 114: 395-9. PMID 24314229 DOI: 10.1111/Bcpt.12168  0.595
2013 Moya PR, Wendland JR, Rubenstein LM, Timpano KR, Heiman GA, Tischfield JA, King RA, Andrews AM, Ramamoorthy S, McMahon FJ, Murphy DL. Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1263-70. PMID 23630162 DOI: 10.1002/Mds.25460  0.61
2013 Stewart SE, Mayerfeld C, Arnold PD, Crane JR, O'Dushlaine C, Fagerness JA, Yu D, Scharf JM, Chan E, Kassam F, Moya PR, Wendland JR, Delorme R, Richter MA, Kennedy JL, et al. Meta-analysis of association between obsessive-compulsive disorder and the 3' region of neuronal glutamate transporter gene SLC1A1. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 162: 367-79. PMID 23606572 DOI: 10.1002/Ajmg.B.32137  0.507
2013 Murphy DL, Moya PR, Fox MA, Rubenstein LM, Wendland JR, Timpano KR. Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 368: 20120435. PMID 23440468 DOI: 10.1098/Rstb.2012.0435  0.469
2013 Moya PR, Dodman NH, Timpano KR, Rubenstein LM, Rana Z, Fried RL, Reichardt LF, Heiman GA, Tischfield JA, King RA, Galdzicka M, Ginns EI, Wendland JR. Rare missense neuronal cadherin gene (CDH2) variants in specific obsessive-compulsive disorder and Tourette disorder phenotypes. European Journal of Human Genetics : Ejhg. 21: 850-4. PMID 23321619 DOI: 10.1038/Ejhg.2012.245  0.409
2013 Fox MA, Panessiti MG, Moya PR, Tolliver TJ, Chen K, Shih JC, Murphy DL. Mutations in monoamine oxidase (MAO) genes in mice lead to hypersensitivity to serotonin-enhancing drugs: implications for drug side effects in humans. The Pharmacogenomics Journal. 13: 551-7. PMID 22964922 DOI: 10.1038/tpj.2012.35  0.442
2013 Moya PR, Wendland JR, Salemme J, Fried RL, Murphy DL. miR-15a and miR-16 regulate serotonin transporter expression in human placental and rat brain raphe cells. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 621-9. PMID 22564678 DOI: 10.1017/S1461145712000454  0.399
2012 Khaibullina A, Kenyon N, Guptill V, Quezado MM, Wang L, Koziol D, Wesley R, Moya PR, Zhang Z, Saha A, Mukherjee AB, Quezado ZM. In a model of Batten disease, palmitoyl protein thioesterase-1 deficiency is associated with brown adipose tissue and thermoregulation abnormalities. Plos One. 7: e48733. PMID 23139814 DOI: 10.1371/journal.pone.0048733  0.303
2012 Sotomayor-Zárate R, Quiroz G, Araya KA, Abarca J, Ibáñez MR, Montecinos A, Guajardo C, Núñez G, Fierro A, Moya PR, Iturriaga-Vásquez P, Gómez-Molina C, Gysling K, Reyes-Parada M. 4-Methylthioamphetamine increases dopamine in the rat striatum and has rewarding effects in vivo. Basic & Clinical Pharmacology & Toxicology. 111: 371-9. PMID 22788961 DOI: 10.1111/j.1742-7843.2012.00926.x  0.606
2011 Moya PR, Fox MA, Jensen CL, Laporte JL, French HT, Wendland JR, Murphy DL. Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout mice. Bmc Pharmacology. 11: 3. PMID 21473759 DOI: 10.1186/1471-2210-11-3  0.492
2011 Murphy DL, Moya PR. Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional G×G and G×E differences in health and disease. Current Opinion in Pharmacology. 11: 3-10. PMID 21439906 DOI: 10.1016/J.Coph.2011.02.008  0.536
2011 Liu X, Cannon DM, Akula N, Moya PR, Knudsen GM, Arentzen TE, Steele J, Laje G, Drevets WC, McMahon FJ. A non-synonymous polymorphism in galactose mutarotase (GALM) is associated with serotonin transporter binding potential in the human thalamus: results of a genome-wide association study. Molecular Psychiatry. 16: 584-5. PMID 21339755 DOI: 10.1038/mp.2011.1  0.356
2011 Omata N, Chiu CT, Moya PR, Leng Y, Wang Z, Hunsberger JG, Leeds P, Chuang DM. Lentivirally mediated GSK-3β silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 711-7. PMID 20604988 DOI: 10.1017/S1461145710000726  0.32
2010 Moya PR, Murphy DL, McMahon FJ, Wendland JR. Increased gene expression of diacylglycerol kinase η in bipolar disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 1127-8. PMID 20519059 DOI: 10.1017/S1461145710000593  0.415
2009 Wendland JR, Moya PR, Timpano KR, Anavitarte AP, Kruse MR, Wheaton MG, Ren-Patterson RF, Murphy DL. A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder. Archives of General Psychiatry. 66: 408-16. PMID 19349310 DOI: 10.1001/Archgenpsychiatry.2009.6  0.504
2008 Murphy DL, Fox MA, Timpano KR, Moya PR, Ren-Patterson R, Andrews AM, Holmes A, Lesch KP, Wendland JR. How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology. 55: 932-60. PMID 18824000 DOI: 10.1016/J.Neuropharm.2008.08.034  0.605
2008 Gobbi M, Funicello M, Gerstbrein K, Holy M, Moya PR, Sotomayor R, Forray MI, Gysling K, Paluzzi S, Bonanno G, Reyes-Parada M, Sitte HH, Mennini T. N,N-dimethyl-thioamphetamine and methyl-thioamphetamine, two non-neurotoxic substrates of 5-HT transporters, have scant in vitro efficacy for the induction of transporter-mediated 5-HT release and currents. Journal of Neurochemistry. 105: 1770-80. PMID 18248615 DOI: 10.1111/J.1471-4159.2008.05272.X  0.398
2008 Wendland JR, Moya PR, Kruse MR, Ren-Patterson RF, Jensen CL, Timpano KR, Murphy DL. A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder. Human Molecular Genetics. 17: 717-23. PMID 18055562 DOI: 10.1093/Hmg/Ddm343  0.535
2007 Moya PR, Berg KA, Gutiérrez-Hernandez MA, Sáez-Briones P, Reyes-Parada M, Cassels BK, Clarke WP. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors. The Journal of Pharmacology and Experimental Therapeutics. 321: 1054-61. PMID 17337633 DOI: 10.1124/jpet.106.117507  0.492
2002 Acuña-Castillo C, Villalobos C, Moya PR, Sáez P, Cassels BK, Huidobro-Toro JP. Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT(2A) and 5-HT(2C) receptors. British Journal of Pharmacology. 136: 510-9. PMID 12055129 DOI: 10.1038/sj.bjp.0704747  0.487
Low-probability matches (unlikely to be authored by this person)
2021 Escobar AP, Martínez-Pinto J, Silva-Olivares F, Sotomayor-Zárate R, Moya PR. Altered Grooming Syntax and Amphetamine-Induced Dopamine Release in EAAT3 Overexpressing Mice. Frontiers in Cellular Neuroscience. 15: 661478. PMID 34234648 DOI: 10.3389/fncel.2021.661478  0.282
2019 Escobar AP, Wendland JR, Chávez AE, Moya PR. The Neuronal Glutamate Transporter EAAT3 in Obsessive-Compulsive Disorder. Frontiers in Pharmacology. 10: 1362. PMID 31803055 DOI: 10.3389/Fphar.2019.01362  0.245
2018 Bonansco C, Martínez-Pinto J, Silva RA, Velásquez VB, Martorell A, Selva MV, Espinosa P, Moya PR, Cruz G, Andrés ME, Sotomayor-Zárate R. Neonatal exposure to estradiol increases dopaminergic transmission in Nucleus Accumbens and morphine-induced conditioned place preference in adult female rats. Journal of Neuroendocrinology. PMID 29377365 DOI: 10.1111/Jne.12574  0.192
2023 Ríos U, Morán J, Hermosilla J, González R, Muñoz P, Arancibia M, Herrera L, Jiménez JP, Moya PR. The interaction of the oxytocin receptor gene and child abuse subtypes on social cognition in euthymic patients with bipolar disorder type I. Frontiers in Psychiatry. 14: 1151397. PMID 37139326 DOI: 10.3389/fpsyt.2023.1151397  0.186
2016 Muñoz P, Aschrafi A, Moya PR. Connecting Synaptic Activity with Plasticity-Related Gene Expression: From Molecular Mechanisms to Neurological Disorders. Neural Plasticity. 2016: 7149527. PMID 27088015 DOI: 10.1155/2016/7149527  0.181
2016 Espinosa P, Silva RA, Sanguinetti NK, Venegas FC, Riquelme R, González LF, Cruz G, Renard GM, Moya PR, Sotomayor-Zárate R. Programming of Dopaminergic Neurons by Neonatal Sex Hormone Exposure: Effects on Dopamine Content and Tyrosine Hydroxylase Expression in Adult Male Rats. Neural Plasticity. 2016: 4569785. PMID 26904299 DOI: 10.1155/2016/4569785  0.175
2019 Cavieres A, Campos-Estrada C, Moya Y, Maldonado R, González-Vargas R, Bustamante ML, Moya PR. Lack of Association between the Gene Asp358Ala Variant (rs2228145), IL-6 Plasma Levels, and Treatment Resistance in Chilean Schizophrenic Patients Treated with Clozapine. Schizophrenia Research and Treatment. 2019: 5601249. PMID 31341681 DOI: 10.1155/2019/5601249  0.155
2023 Crowley JJ, Cappi C, Ochoa-Panaifo ME, Frederick RM, Kook M, Wiese AD, Rancourt D, Atkinson EG, Giusti-Rodriguez P, Anderberg JL, Abramowitz JS, Adorno VR, Aguirre C, Alves GS, Alves GS, ... ... Moya PR, et al. Latin American Trans-ancestry INitiative for OCD genomics (LATINO): Study protocol. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. e32962. PMID 37946624 DOI: 10.1002/ajmg.b.32962  0.143
2023 Crowley JJ, Cappi C, Ochoa-Panaifo ME, Frederick RM, Kook M, Wiese AD, Rancourt D, Atkinson EG, Giusti-Rodriguez P, Anderberg JL, Abramowitz JS, Adorno VR, Aguirre C, Alves GS, Alves GS, ... ... Moya PR, et al. Latin American Trans-ancestry INitiative for OCD genomics (LATINO): Study Protocol. Medrxiv : the Preprint Server For Health Sciences. PMID 37131804 DOI: 10.1101/2023.02.23.23286373  0.143
2020 Ríos U, Moya PR, Urrejola Ó, Hermosilla J, Gonzalez R, Muñoz P, Moran J, Solervicens P, Jiménez JP. [History of child abuse among patients with bipolar disorders]. Revista Medica De Chile. 148: 204-210. PMID 32730497 DOI: 10.4067/s0034-98872020000200204  0.139
2017 Ahumada C, Bahamondes C, Cerda CA, Silva RA, Cruz G, Moya PR, Sotomayor-Zárate R, Renard GM. Amphetamine treatment affects the extra-hypothalamic vasopressinergic system in a sex- and nucleus-dependent manner. Journal of Neuroendocrinology. PMID 28235136 DOI: 10.1111/jne.12465  0.136
2019 Pérez MÁ, Morales C, Santander O, García F, Gómez I, Peñaloza-Sancho V, Fuentealba P, Dagnino-Subiabre A, Moya PR, Fuenzalida M. Ketamine-Treatment During Late Adolescence Impairs Inhibitory Synaptic Transmission in the Prefrontal Cortex and Working Memory in Adult Rats. Frontiers in Cellular Neuroscience. 13: 372. PMID 31481877 DOI: 10.3389/fncel.2019.00372  0.134
2020 Riquelme-Alcázar J, González-Vargas R, Moya PR. [ABC transporters and drug resistance in epilepsy: biological plausibility, pharmacogenetics and precision medicine]. Revista De Neurologia. 70: 23-32. PMID 31845753 DOI: 10.33588/rn.7001.2019188  0.119
2021 Spaas J, van Veggel L, Schepers M, Tiane A, van Horssen J, Wilson DM, Moya PR, Piccart E, Hellings N, Eijnde BO, Derave W, Schreiber R, Vanmierlo T. Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders. Cellular and Molecular Life Sciences : Cmls. PMID 33751149 DOI: 10.1007/s00018-021-03802-0  0.116
2023 Illesca-Matus R, Ardiles NM, Munoz F, Moya PR. Implications of Physical Exercise on Episodic Memory and Anxiety: The Role of the Serotonergic System. International Journal of Molecular Sciences. 24. PMID 37511128 DOI: 10.3390/ijms241411372  0.11
2023 Pérez-Núñez R, Chamorro A, González MF, Contreras P, Artigas R, Corvalán AH, van Zundert B, Reyes C, Moya PR, Avalos AM, Schneider P, Quest AFG, Leyton L. Protein kinase B (AKT) upregulation and Thy-1-αβ integrin-induced phosphorylation of Connexin43 by activated AKT in astrogliosis. Journal of Neuroinflammation. 20: 5. PMID 36609298 DOI: 10.1186/s12974-022-02677-7  0.109
2022 Zazueta A, Castillo T, Cavieres Á, González R, Abarca M, Nieto RR, Deneken J, Araneda C, Moya PR, Bustamante ML. Polymorphisms in schizophrenia-related genes are potential predictors of antipsychotic treatment resistance and refractoriness. The International Journal of Neuropsychopharmacology. PMID 35416253 DOI: 10.1093/ijnp/pyac025  0.107
2003 Valdecantos P, Briones R, Moya P, Germain A, Huidobro-Toro JP. Pharmacological identification of P2X1, P2X4 and P2X7 nucleotide receptors in the smooth muscles of human umbilical cord and chorionic blood vessels Placenta. 24: 17-26. PMID 12495655 DOI: 10.1053/plac.2002.0862  0.088
2015 Faas AE, March SM, Moya PR, Molina JC. Alcohol odor elicits appetitive facial expressions in human neonates prenatally exposed to the drug. Physiology & Behavior. 148: 78-86. PMID 25707382 DOI: 10.1016/j.physbeh.2015.02.031  0.087
2000 Faas AE, Spontón ED, Moya PR, Molina JC. Differential responsiveness to alcohol odor in human neonates: effects of maternal consumption during gestation. Alcohol (Fayetteville, N.Y.). 22: 7-17. PMID 11109023 DOI: 10.1016/S0741-8329(00)00103-8  0.069
2013 Faas AE, Resino CF, Moya PR. Neonatal responsiveness to the odor of amniotic fluid. Archivos Argentinos De Pediatrã­A. 111: 105-9. PMID 23568065 DOI: 10.1590/S0325-00752013000200004  0.053
2006 Cerdeño ML, Rodríguez-Caderot G, Moya PR, Ibarra A, Herrero S. Studies of archaeoastronomy in Spain: A review | Los estudios de arqueoastronomía en España: Estado de la cuestión Trabajos De Prehistoria. 63: 13-34.  0.033
1988 Moya PR, Trombotto GT. [Chagas' disease: clastogenic effect of nifurtimox and benznidazole in children]. Medicina. 48: 487-91. PMID 3151216  0.029
1979 Moya PR, Villagra L, Risco J. [Congenital Chagas disease: anatomopathological findings in the placenta and umbilical cord]. Revista De La Facultad De Ciencias Mã©Dicas De Cã³Rdoba. 37: 21-7. PMID 122217  0.028
2018 Moya PR, Wendland JR, Fox MA. Dennis Luke Murphy, M.D. (1936-2017). Genes, Brain, and Behavior. 17: e12455. PMID 29596735 DOI: 10.1111/gbb.12455  0.021
1973 Moya PR, Ayan De Turco S, De Paolasso RW. Acute diarrhea in the neonatal period | DIARREA AGUDA EN EL PERIODO NEONATAL Pediat.Panam.. 2: 78-117.  0.012
1985 Moya PR, Paolasso RD, Blanco S, Lapasset M, Sanmartino C, Basso B, Moretti E, Cura D. [Treatment of Chagas' disease with nifurtimox during the first months of life]. Medicina. 45: 553-8. PMID 3939553  0.01
Hide low-probability matches.